Drugs & FDA Twenty Years, Four Botanical Drugs: The FDA Wants to Know What's Blocking the Rest
Four botanical drugs in two decades, under a framework built for single molecules. Now, inside RFK Jr.'s HHS, the agency that wrote those rules is asking what blocked the rest, and whether it means it.
By Marcus Chen · September 17, 2026